You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 105 No. 1, JANUARY 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Agranulocytosis Associated with Phenindione

A Case Report with Review of the Literature

ARMEN H. TASHJIAN, Jr.; JOHN P. LEDDY

AMA Arch Intern Med. 1960;105(1):121-125.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the eleven years since the first clinical use1 of phenindione (2 phenyl-1,3 indandione)* as a hypoprothrombinemic agent, there have been five case reports of agranulocytosis,2-5 one of severe neutropenia (but with eosinophilia),6 and one of granulocytopenia 7 associated with the use of this drug; one death was attributable to this complication. The following report concerns another case of agranulocytosis associated with phenindione therapy in which recovery occurred.

Report of Case

A 49-year-old white woman entered the Boston City Hospital for the ninth time on May 3, 1958, because of dyspnea. Previous admissions were for decompensated rheumatic heart disease. Eleven weeks preceding this admission, she had entered the surgical service with an embolus to the right femoral artery, for which a successful embolectomy was performed. Her recovery was uneventful, and she was discharged taking phenindione, 50 mg. twice daily, digitalis folia, 0.1 gm. daily, and oral penicillin . . . [Full Text PDF of this Article]


Author Affiliations

Boston

From the Thorndike Memorial Laboratory and Second and Fourth (Harvard) Medical Services, Boston City Hospital, and the Department of Medicine, Harvard Medical School.; Formerly Assistant Resident in Medicine, Second and Fourth (Harvard) Medical Services, Boston City Hospital (Dr. Tashjian).; Formerly Resident in Medicine, Second and Fourth (Harvard) Medical Services, Boston City Hospital; Assistant in Medicine, Harvard Medical School (Dr. Leddy).


Footnotes

Submitted for publication May 8, 1959.

Also known as phenylindanedione, P.I.D., Danilone, Hedulin, Dindevan, Eridone, and Trombantin.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.